Osaic Holdings
SNTI icon

Osaic Holdings’s Senti Biosciences Holdings SNTI Stock Holding History

Osaic Holdings’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,400
Closed -$21.5K – 7879
2025
Q1 		$21.5K Buy
+6,400
New +$24.9K ﹤0.01% 5319

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings's SNTI Position: Q2 2025 in Review

Osaic Holdings sold out of Senti Biosciences Holdings (SNTI) in Q2 2025, closing a stake of 6,400 shares — an estimated $21.5K sold.

Osaic Holdings first reported a position in SNTI in Q1 2025 and held it in 1 quarter. The position peaked at $21.5K in Q1 2025. 15 funds tracked by Wall St. Rank hold SNTI as of Q2 2025.

  • Osaic Holdings reported no remaining Senti Biosciences Holdings position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 6,400 Senti Biosciences Holdings shares in Q2 2025, an estimated $21.5K.
  • Osaic Holdings first reported a position in Senti Biosciences Holdings in Q1 2025 and held it in 1 quarter.
  • Osaic Holdings's Senti Biosciences Holdings position peaked at $21.5K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.